Optum to acquire 230-physician Reliant Medical Group in Massachusetts

Eden Prairie, Minn.-based OptumHealth, a subsidiary of Minnetonka, Minn.-based UnitedHealthcare, revealed plans to acquire Reliant Medical Group, a physician group in Worcester, Mass.

Advertisement

Members of the 230-physician organization unanimously voted to approve the proposed acquisition May 9. The group’s board of trustees approved the deal during a vote in April, according to the report.

A spokesperson for Reliant told the Worcester Business Journal Online the medical group does not have plans to terminate any of its 2,500 employees.

The organizations will move toward signing a definitive acquisition agreement. The proposed deal is subject to regulatory approval. If approved, Reliant will continue to be locally governed and retain its brand, according to the WBJO report.

“This is the beginning of a process that will strengthen Reliant and position the organization for continued success in the ever-changing and challenging healthcare industry,” said Tarek Elsawy, MD, president and CEO of Reliant Medical Group.

More articles on hospital-physician relationships:
2 Boston physicians found slain in condominium
California physician delivers own baby en route to hospital
Tacoma General Hospital celebrates oldest working registered nurse at 92

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The 2 KPIs that drive readmissions — and how hospitals act on them in real time

Tuesday, August 11
1:00 PM - 2:00 PM CDT

Presenter: Nik Rao, Dexur

Advertisement

Next Up in Integration & Physician Issues

Advertisement

Comments are closed.